Monitoring M-Proteins in Patients with Multiple Myeloma Using Heavy-Chain Variable Region Clonotypic Peptides and LC

Monitoring M-Proteins in Patients with Multiple Myeloma Using Heavy-Chain Variable Region Clonotypic Peptides and LC–MS/MS

Published:2014-03-05 Issue:4 Volume:13 Page:1905-1910
ISSN:1535-3893
Container-title:Journal of Proteome Research
language:en
Short-container-title:J. Proteome Res.

Author:

Barnidge David R.¹,Tschumper Renee C.¹,Theis Jason D.¹,Snyder Melissa R.¹,Jelinek Diane F.¹,Katzmann Jerry A.¹,Dispenzieri Angela¹,Murray David L.¹

Affiliation:

1. Department of Laboratory Medicine and Pathology, ‡Department of Immunology, §Department of Hematology, Mayo Clinic, Rochester, Minnesota 55905, United States

Publisher

American Chemical Society (ACS)

Subject

General Chemistry,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/pr5000544

Reference15 articles.

1. Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma

2. Screening Panels for Detection of Monoclonal Gammopathies

3. Review of 1027 Patients With Newly Diagnosed Multiple Myeloma

4. Treatment of Multiple Myeloma: A Comprehensive Review

5. Treatment of Newly Diagnosed Multiple Myeloma Based on Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART): Consensus Statement

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An automated workflow based on data independent acquisition for practical and high-throughput personalized assay development and minimal residual disease monitoring in multiple myeloma patients;Clinical Chemistry and Laboratory Medicine (CCLM);2024-06-17

2. Endogenous monoclonal immunoglobulins analyzed using the EXENT® solution and LC-MS;Journal of Mass Spectrometry and Advances in the Clinical Lab;2024-04

3. N-linked glycosylation of the M-protein variable region: glycoproteogenomics reveals a new layer of personalized complexity in multiple myeloma;Clinical Chemistry and Laboratory Medicine (CCLM);2024-02-09

4. Monitoring Minimal Residual Disease in Patients with Multiple Myeloma by Targeted Tracking Serum M-Protein Using Mass Spectrometry (EasyM);Clinical Cancer Research;2024-01-03

5. A sensitive high-resolution mass spectrometry method for quantifying intact M-protein light chains in patients with multiple myeloma;Clinica Chimica Acta;2024-01